Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Bone Loss and High Bone Turnover in Patients with Non-Hodgkin's Lymphoma Who Receive Frontline Chemotherapy: Final Results of a Multicenter Prospective Study

Evangelos Terpos, MD PhD, Despina Fotiou, MD, Konstantinos Anargyrou, MD, Theodoros P. Vassilakopoulos, MD PhD, Dimitrios Christoulas, MD, Polyzois Makras, MD PhD, Maria Dimou, MD PhD, Ioannis Ntanasis-Stathopoulos, MD, Stavroula Masouridou, MD, Maria K. Angelopoulou, MD, Athanasios Papatheodorou, PhD, Konstantinos Tsionos, MD, Panayiotis Panayiotidis, MD, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_1): 4124.

https://doi.org/10.1182/blood-2019-123615

Published: 2019

Journal Articles

Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease

Luca Dalle Carbonare, Alessandro Matte’, Maria Teresa Valenti, Angela Siciliano, Antonio Mori, Vittorio Schweiger, Gino Zampieri, Luigi Perbellini, Lucia De Franceschi

Blood (2015) 126 (20): 2320–2328.

https://doi.org/10.1182/blood-2015-04-641969

Published: 2015

Includes: Supplemental data

Journal Articles

Correlation Between Markers of Bone Turnover and Vitamin D Levels in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)

Brea C. Lipe, MD, Tara L. Lin, MD, Omar S. Aljitawi, MD, Abdulraheem Yacoub, MD, Ruben Reyes, MD, Suman Kambhampati, MD, Peter van Veldhuizen, MD, Joseph R. Mikhael, MD

Blood (2014) 124 (21): 3471.

https://doi.org/10.1182/blood.V124.21.3471.3471

Published: 2014

Journal Articles

High Bone Turnover Is Present in Patients with Primary Systemic (AL) Amyloidosis and Increased Osteoprotegerin Identifies Patients with Poor Survival within Mayo Stage 1 Disease

Efstathios Kastritis, MD, Maria Gavriatopoulou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Maria Roussou, Constantinos Pamboucas, Savvas Th. Toumanidis, Evangelos Terpos, Meletios A. Dimopoulos

Blood (2014) 124 (21): 2028.

https://doi.org/10.1182/blood.V124.21.2028.2028

Published: 2014

Journal Articles

Bone Turnover In Multiple Myeloma: Impact Of Bortezomib-Based Induction Therapy, High-Dose Melphalan, and Lenalidomide Consolidation On Osteoblast and Osteoclast Function Within The GMMG-MM5 Trial

Anja Seckinger, MD, Tobias Meißner, PhD, Uta Bertsch, MD, Hans Salwender, MD, Jan Dürig, MD, Mathias Hänel, MD, Igor W. Blau, MD, Christof Scheid, MD, Katja Weisel, MD, Bernard Klein, PhD, Hartmut Goldschmidt, MD, Dirk Hose, Dr. med. dipl.-phys.

Blood (2013) 122 (21): 1863.

https://doi.org/10.1182/blood.V122.21.1863.1863

Published: 2013

Journal Articles

Bone Turnover Biomarkers Are Useful In Monitoring Myeloma Bone Disease and As Early Predictor Biomarkers For Relapse Disease In Multiple Myeloma

Kay Reen Ting, MB Bch BAO, Abdul Hameed, MBBS, MRCP, Jennifer Brady, Paul Dowling, PhD, Colin Clarke, PhD, Justine Meiller, Constantine S. Mitsiades, MD, PhD, Paul G. Richardson, MD, Kenneth C. Anderson, MD, Martin Clynes, PhD, Peter O'Gorman, MD, PhD

Blood (2013) 122 (21): 1869.

https://doi.org/10.1182/blood.V122.21.1869.1869

Published: 2013

Journal Articles

The Clinical Utility Of Bone Turnover Markers In The Evaluation Of Bone Disease In Patients With Haemophilia A and B

Panagiotis Anagnostis, MD, PhD, Sofia Vakalopoulou, MD, PhD, Vyzantiadis Timoleon-Achilleas, MD, PhD, Maria Charizopoulou, Eudokia M. Mandala, Alexandra Agapidou, MD, Violaki Vassiliki, MD, Garipidou Vasilia, MD, PhD

Blood (2013) 122 (21): 3612.

https://doi.org/10.1182/blood.V122.21.3612.3612

Published: 2013

Journal Articles

Reduced HMOX1 Expression in Myelomatous Bones Is Associated with Poor Survival and Its Induction Regulates Osteoclastogenesis and Osteoblastogenesis

Xin Li, PhD, Qing Zhang, PhD, Sarah K. Johnson, PhD, Wen Ling, MS, Sharmin Khan, MS, Frits van Rhee, MD, PhD, Saad Z Usmani, MD FACP, Sarah Waheed, MD, Bart Barlogie, MD, PhD, Joshua Epstein, DSc, Shmuel Yaccoby, PhD

Blood (2012) 120 (21): 1815.

https://doi.org/10.1182/blood.V120.21.1815.1815

Published: 2012

Journal Articles

Usefulness of Biochemical Markers of Bone Turnover in the Evaluation of Venezuelan Patients with Multiple Myeloma

Eugenio Ionescu, MD, Edmundo Martinez, MD, Leonor Cardenas, MD, Dalal Zoghbi, MD

Blood (2012) 120 (21): 5003.

https://doi.org/10.1182/blood.V120.21.5003.5003

Published: 2012

Journal Articles

Patients with POEMS Syndrome Have High Bone Turnover and Increased Circulating Angiogenic Cytokines; Should Angiopoietin-2 and Bone-Specific Alkaline Phosphatase Be Used As Minor Criteria for the Diagnosis of the Disease?

Evangelos Terpos, Meletios Athanasios Dimopoulos, MD, Stephanie Harel, MD, Francis K Buadi, M.D., Dimitrios Christoulas, Ersi Voskaridou, Efstathios Kastritis, Jean Paul Fermand, MD, Angela Dispenzieri, MD

Blood (2011) 118 (21): 806.

https://doi.org/10.1182/blood.V118.21.806.806

Published: 2011

Journal Articles

Bone Turnover Markers In Gaucher Disease Patients.

Gaetano Giuffrida, Maria Rocca Cingari, Nunziatina Parrinello, Alessandra Romano, Anna Triolo, Magda Franceschino, Francesco Di Raimondo

Blood (2010) 116 (21): 3780.

https://doi.org/10.1182/blood.V116.21.3780.3780

Published: 2010

Journal Articles

Low Bone Mineral Density and High Bone Turnover In Patients with Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study

Konstantinos Anargyrou, Theodoros P. Vassilakopoulos, Konstantinos Tsionos, Panayiotis Kokkoris, Georgios Boutsikas, Maria K. Angelopoulou, Dimitrios Christoulas, Stavroula Masouridou, Maria Dimou, Athanasios Papatheodorou, Danos N. Chatzifotiadis, Panayiotis Panayiotidis, Gerasimos A. Pangalis, Photis Beris, Evangelos Terpos

Blood (2010) 116 (21): 5071.

https://doi.org/10.1182/blood.V116.21.5071.5071

Published: 2010

Journal Articles

First-Line Chemotherapy Leads to High Bone Turnover and Reduced Bone Mass in Patients with Non-Hodgkin's Lymphoma (NHL).

Blood (2009) 114 (22): 1951.

https://doi.org/10.1182/blood.V114.22.1951.1951

Published: 2009

Journal Articles

Coordinated Regulation of Hematopoietic and Mesenchymal Stem Cells in a Bone Marrow Niche.

Simón Méndez-Ferrer, PhD, Tatyana V. Michurina, Francesca Ferraro, Amin Mazloom, Ben MacArthur, Sergio Lira, MD, PhD, David T. Scadden, MD, Avi Ma'ayan, Grigori N. Enikolopov, PhD, Paul S. Frenette, MD

Blood (2009) 114 (22): 2.

https://doi.org/10.1182/blood.V114.22.2.2

Published: 2009

Journal Articles

High Bone Turnover and Increased Angiogenesis Cytokines in Patients with POEMS Syndrome.

Evangelos Terpos, Meletios A. Dimopoulos, Ersi Voskaridou, Angela Dispenzieri

Blood (2007) 110 (11): 3525.

https://doi.org/10.1182/blood.V110.11.3525.3525

Published: 2007

Journal Articles

Analysis of Bone Mineral Density, Biochemical Bone Turnover Markers and Serum Tryptase Levels in Patients with Systemic Mastocytosis (SM).

Akif S. Yavuz, Nilüfer Alpay, Öner Dogan, Nesimi Büyükbabani, Can Baykal, Dilsad Sindel, Yüksel Pekçelen, Refik Tanakol

Blood (2007) 110 (11): 4662.

https://doi.org/10.1182/blood.V110.11.4662.4662

Published: 2007

Journal Articles

Myeloma Cells Suppress Osteoblast Differentiation by Secreting a Soluble Wnt Inhibitor, sFRP-2.

Takashi Oshima, MD, Masahiro Abe, MD, Jin Asano, MD, Tomoko Hara, MD, Kenichi Kitazoe, MD, Etsuko Sekimoto, MD, Yoichi Tanaka, MD, Hironobu Shibata, MD, Toshihiro Hashimoto, MD, Shuji Ozaki, MD, Shinsuke Kido, MD, Daisuke Inoue, MD, Toshio Matsumoto, MD

Blood (2004) 104 (11): 2356.

https://doi.org/10.1182/blood.V104.11.2356.2356

Published: 2004

Journal Articles

Biochemical markers of bone turnover following high-dose chemotherapy and autografting in multiple myeloma

Richard E. Clark, Angela J. Flory, Edwina M. Ion, Barry E. Woodcock, Brian H. Durham, William D. Fraser

Blood (2000) 96 (8): 2697–2702.

https://doi.org/10.1182/blood.V96.8.2697

Published: 2000

NARROW

Bone Loss and High Bone Turnover in Patients with Non-Hodgkin's Lymphoma Who Receive Frontline Chemotherapy: Final Results of a Multicenter Prospective Study

Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease

Correlation Between Markers of Bone Turnover and Vitamin D Levels in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)

High Bone Turnover Is Present in Patients with Primary Systemic (AL) Amyloidosis and Increased Osteoprotegerin Identifies Patients with Poor Survival within Mayo Stage 1 Disease

Bone Turnover In Multiple Myeloma: Impact Of Bortezomib-Based Induction Therapy, High-Dose Melphalan, and Lenalidomide Consolidation On Osteoblast and Osteoclast Function Within The GMMG-MM5 Trial

Bone Turnover Biomarkers Are Useful In Monitoring Myeloma Bone Disease and As Early Predictor Biomarkers For Relapse Disease In Multiple Myeloma

The Clinical Utility Of Bone Turnover Markers In The Evaluation Of Bone Disease In Patients With Haemophilia A and B

Reduced HMOX1 Expression in Myelomatous Bones Is Associated with Poor Survival and Its Induction Regulates Osteoclastogenesis and Osteoblastogenesis

Usefulness of Biochemical Markers of Bone Turnover in the Evaluation of Venezuelan Patients with Multiple Myeloma

Patients with POEMS Syndrome Have High Bone Turnover and Increased Circulating Angiogenic Cytokines; Should Angiopoietin-2 and Bone-Specific Alkaline Phosphatase Be Used As Minor Criteria for the Diagnosis of the Disease?

Bone Turnover Markers In Gaucher Disease Patients.

Low Bone Mineral Density and High Bone Turnover In Patients with Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study

First-Line Chemotherapy Leads to High Bone Turnover and Reduced Bone Mass in Patients with Non-Hodgkin's Lymphoma (NHL).

Coordinated Regulation of Hematopoietic and Mesenchymal Stem Cells in a Bone Marrow Niche.

High Bone Turnover and Increased Angiogenesis Cytokines in Patients with POEMS Syndrome.

Analysis of Bone Mineral Density, Biochemical Bone Turnover Markers and Serum Tryptase Levels in Patients with Systemic Mastocytosis (SM).

Myeloma Cells Suppress Osteoblast Differentiation by Secreting a Soluble Wnt Inhibitor, sFRP-2.

Biochemical markers of bone turnover following high-dose chemotherapy and autografting in multiple myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only